Tag: Cancer: Ovarian
Sales of Johnson’s Baby Powder Halted in U.S., Canada
Johnson & Johnson says talc-based powder is safe and will still be sold in other countries
Use of Powder in Genital Area Not Linked to Ovarian Cancer
Frequent versus never use, long-term versus never use not significantly associated with higher risk
Addition of Maintenance Olaparib Slows Advanced Ovarian Cancer
Benefit substantial for homologous-recombination deficiency positive tumors with, without BRCA mutations
Secondary Surgical Cytoreduction Not Superior in Ovarian Cancer
Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer
CA125 Can Detect Ovarian Cancer in General Practice
And elevated CA125 indicates higher risk for other cancers, especially in women aged ≥50 years
J&J Says No Asbestos Detected in New Tests of Baby Powder
Tests were performed by two third-party laboratories as part of the company's ongoing investigation
Johnson & Johnson Recalls Baby Powder Due to Presence of Asbestos
This is the first time Johnson & Johnson has pulled its baby powder from the market
PARP Inhibitor Slows Progression of Advanced Ovarian Cancer
Veliparib added to chemotherapy, continued as maintenance tx prolongs progression-free survival
PTSD Symptoms Tied to Higher Risk for Ovarian Cancer
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors
Intrauterine Device Use May Reduce Incidence of Ovarian Cancer
Novel noncontraceptive benefit seen for all intrauterine devices
